These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 17368006)

  • 1. Nasal residence of insulin containing lyophilised nasal insert formulations, using gamma scintigraphy.
    McInnes FJ; O'Mahony B; Lindsay B; Band J; Wilson CG; Hodges LA; Stevens HN
    Eur J Pharm Sci; 2007 May; 31(1):25-31. PubMed ID: 17368006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo evaluation of nicotine lyophilised nasal insert in sheep.
    McInnes FJ; Thapa P; Baillie AJ; Welling PG; Watson DG; Gibson I; Nolan A; Stevens HN
    Int J Pharm; 2005 Nov; 304(1-2):72-82. PubMed ID: 16183221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of deposition and spray pattern of nasal powders on insulin bioavailability.
    Pringels E; Callens C; Vervaet C; Dumont F; Slegers G; Foreman P; Remon JP
    Int J Pharm; 2006 Mar; 310(1-2):1-7. PubMed ID: 16427222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of simple dynamic mucosal models and confocal microscopy for the evaluation of lyophilised nasal formulations.
    McInnes F; Baillie AJ; Stevens HN
    J Pharm Pharmacol; 2007 Jun; 59(6):759-67. PubMed ID: 17637168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gamma scintigraphy for testing bioequivalence: a case study on two cromolyn sodium nasal spray preparations.
    Al-Ghananeem AM; Sandefer EP; Doll WJ; Page RC; Chang Y; Digenis GA
    Int J Pharm; 2008 Jun; 357(1-2):70-6. PubMed ID: 18329197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distribution and clearance of bioadhesive formulations from the olfactory region in man: effect of polymer type and nasal delivery device.
    Charlton S; Jones NS; Davis SS; Illum L
    Eur J Pharm Sci; 2007 Mar; 30(3-4):295-302. PubMed ID: 17223022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nasal deposition and clearance in man: comparison of a bidirectional powder device and a traditional liquid spray pump.
    Djupesland PG; Skretting A
    J Aerosol Med Pulm Drug Deliv; 2012 Oct; 25(5):280-9. PubMed ID: 22251061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clearance characteristics of chitosan based formulations in the sheep nasal cavity.
    Soane RJ; Hinchcliffe M; Davis SS; Illum L
    Int J Pharm; 2001 Apr; 217(1-2):183-91. PubMed ID: 11292554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The distribution of an intranasal insulin formulation in healthy volunteers: effect of different administration techniques.
    Newman SP; Steed KP; Hardy JG; Wilding IR; Hooper G; Sparrow RA
    J Pharm Pharmacol; 1994 Aug; 46(8):657-60. PubMed ID: 7815279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nasal distribution of radioactive drug administered using two dosage forms.
    Vidgren P; Vidgren M; Paronen P; Vainio P; Nuutinen J
    Eur J Drug Metab Pharmacokinet; 1991; Spec No 3():426-32. PubMed ID: 1820917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of novel bioadhesive granisetron hydrochloride spanlastic gel and insert for brain targeting and study their effects on rats.
    Abdelmonem R; El Nabarawi M; Attia A
    Drug Deliv; 2018 Nov; 25(1):70-77. PubMed ID: 29228824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid emulsions as vehicles for enhanced nasal delivery of insulin.
    Mitra R; Pezron I; Chu WA; Mitra AK
    Int J Pharm; 2000 Sep; 205(1-2):127-34. PubMed ID: 11000549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin Delivery to the Brain via the Nasal Route: Unraveling the Potential for Alzheimer's Disease Therapy.
    Wong CYJ; Baldelli A; Hoyos CM; Tietz O; Ong HX; Traini D
    Drug Deliv Transl Res; 2024 Jul; 14(7):1776-1793. PubMed ID: 38441832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of ISCOM matrices clearance from rabbit nasal cavity by γ scintigraphy.
    Pandey RS; Babbar AK; Kaul A; Mishra AK; Dixit VK
    Int J Pharm; 2010 Oct; 398(1-2):231-6. PubMed ID: 20688140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of bioadhesive polymers, sodium salicylate, polyoxyethylene-9-lauryl ether, and method of preparation on the relative hypoglycemia produced by insulin enteric-coated capsules in diabetic beagle dogs.
    Hosny EA; al-Shora HI; Elmazar MM
    Drug Dev Ind Pharm; 2002 May; 28(5):563-70. PubMed ID: 12098845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterisation of nasal devices for delivery of insulin to the brain and evaluation in humans using functional magnetic resonance imaging.
    Wingrove J; Swedrowska M; Scherließ R; Parry M; Ramjeeawon M; Taylor D; Gauthier G; Brown L; Amiel S; Zelaya F; Forbes B
    J Control Release; 2019 May; 302():140-147. PubMed ID: 30953665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intranasal bioavailability of insulin from carbopol-based gel spray in rabbits.
    Najafabadi AR; Moslemi P; Tajerzadeh H
    Drug Deliv; 2004; 11(5):295-300. PubMed ID: 15742554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel nano-cellulose excipient for generating non-Newtonian droplets for targeted nasal drug delivery.
    Young PM; Traini D; Ong HX; Granieri A; Zhu B; Scalia S; Song J; Spicer PT
    Drug Dev Ind Pharm; 2017 Oct; 43(10):1729-1733. PubMed ID: 28581833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulsating aerosols for drug delivery to the sinuses in healthy volunteers.
    Möller W; Schuschnig U; Khadem Saba G; Meyer G; Junge-Hülsing B; Keller M; Häussinger K
    Otolaryngol Head Neck Surg; 2010 Mar; 142(3):382-8. PubMed ID: 20172385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug delivery to the nasal cavity: in vitro and in vivo assessment.
    Newman SP; Pitcairn GR; Dalby RN
    Crit Rev Ther Drug Carrier Syst; 2004; 21(1):21-66. PubMed ID: 15099184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.